
‘Biosimilar’ drug Ogviri approved by FDA for breast and stomach cancer

For the treatment of certain breast and stomach cancers, the U.S. Food and Drug Administration (FDA) recently approved Ogiviri (tastuzumab–dkst), which is the nation’s first biosimilar drug.
FDA said that the newly designed biosimilar are derivative of living organisms and similar to those drugs that had been approved earlier. Moreover, it was found that there is no significant difference between their potency, safety, and purity.
It was reported that Ogviri is approved to treat breast or stomach cancers that are associated with HER2+ gene.
FDA Commissioner, Dr. Scott Gottlieb said, “The FDA continues to grow the number of biosimilar approvals, helping to promote competition that can lower health care costs”. He further added that it is very important to introduce such drugs when the concern is cancer, whose treatment is high costly and can’t be afforded by many.
Certain side effects are expected and reported like headache, chills, fever, diarrhea, nausea, infection, cough, etc.
Like Herceptin, Ogviri box is labeled with a warning stating the risk of heart diseases, serious allergic reactions, lung damage and damage to developing fetus.
Source: drugs.com
FDA has furnished a warning letter regarding the male enhancement products which are unapproved and available at gas stations. It may seem fun to try those inexpensive but unreliable...
First prescription cannabidiol medicine has been voted by Federal Advisors for recommendation to get approval for treating epilepsy. Even the US. FDA advisory committee has voted in unison for...
Scientists at Cancer Research UK have demonstrated the role of alcohol in damaging DNA in stem cells. This explains how drinking increases the risk of cancer. Most of the research...
Presently, people at a moderate risk of developing colon cancer are suggested to get the screening done at the age of 50. However, a recent research indicates that it...
In a recent survey, when people were asked to identify the causes of cancer, they identified tobacco use as a causative factor of cancer, but only 30% identified use...
Proton pump inhibitors (PPPIs) or heartburn and acid reflux drugs are widely used medicines across the world. However, a new study suggested that these drugs, might significantly increase the...